MALARA, GIOVANNA
 Distribuzione geografica
Continente #
NA - Nord America 229
Continente sconosciuto - Info sul continente non disponibili 150
EU - Europa 9
AS - Asia 3
Totale 391
Nazione #
US - Stati Uniti d'America 205
CA - Canada 10
IT - Italia 9
PR - Porto Rico 3
CR - Costa Rica 2
JM - Giamaica 2
NI - Nicaragua 2
BB - Barbados 1
BZ - Belize 1
CN - Cina 1
HK - Hong Kong 1
HN - Honduras 1
LC - Santa Lucia 1
SG - Singapore 1
TT - Trinidad e Tobago 1
Totale 241
Città #
Newark 17
San Jose 10
Messina 6
Ashburn 5
Chicago 4
North Kansas City 4
Queens 4
Atlanta 3
Los Angeles 3
Montreal 3
Washington 3
Boston 2
Brooklyn 2
Charlotte 2
Eatontown 2
Houston 2
Jacksonville 2
Kingston 2
Las Vegas 2
New York 2
Philadelphia 2
Richmond 2
San Antonio 2
San Francisco 2
San José 2
Akron 1
Augusta 1
Baltimore 1
Bayamón 1
Bayonne 1
Beachwood 1
Bear 1
Beijing 1
Belize City 1
Bensalem 1
Bridgetown 1
Burlington 1
Canton 1
Carteret 1
Cary 1
Castries 1
Cedar Hill 1
Chaguanas 1
Cidra 1
Colorado Springs 1
Columbia 1
Dallas 1
Dover Plains 1
East Providence 1
Elberton 1
Elkton 1
Fort Lauderdale 1
Fort Payne 1
Fredericton 1
Fullerton 1
Gatineau 1
Georgetown 1
Glendale 1
Goldsboro 1
Grand Saline 1
Green Bay 1
Hackettstown 1
Hamilton 1
Hazel Crest 1
Hemet 1
Hong Kong 1
Iron Station 1
Kewanee 1
Knoxville 1
León 1
Managua 1
Mansfield 1
Miami 1
Niagara Falls 1
Norfolk 1
North York 1
O'Fallon 1
Ontario 1
Pembroke 1
Perth Amboy 1
Petersburg 1
Phoenix 1
Ponce 1
Princeton 1
Santa Clara 1
Schenectady 1
Scranton 1
Sevierville 1
Silver Spring 1
St Louis 1
St. George 1
Swainsboro 1
Tampa 1
The Bronx 1
Thornhill 1
Toledo 1
Trinity 1
Troy 1
Tustin 1
Waldorf 1
Totale 165
Nome #
Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert Panel 11
Secukinumab nella psoriasi a placche: dai trials clinici alla real evidence 9
Safe and effective approach of 4 immune-mediated inflammatory diseases with 1 biologic: Our results 9
Undiagnosed psoriatic arthritis in some patients under ustekinumb treatment for psoriasis: Radiologic evolutions of joints involved in the subsequent diagnosis of psoriatic arthritis 9
Ustekinumab treatment in psoriatic patient suffering from chronic hepatitis C 8
Radiologic evolutions in patients suffering from psoriatic arthritis in treatment with adalimumab over 1 year 8
Observation of the behavior of cell-mediated immunity in psoriatic patients treated with ustekinumab: Early results 8
MANAGEMENT OF PSORIATIC ARTHRITIS: SHOULD THE INTERACTION BETWEEN DERMATOLOGISTS AND RHEUMATOLOGISTS IN CLINICAL PRACTICE BE INTENSIFIED? 8
PSORIASI CONOSCENZA E CURA Un approccio multidisciplinare dalla diagnosi alla terapia. 8
Improving the disease awareness: how a communication campaign brings hidradenitis suppurativa to the light 8
Is apremilast a promising treatment for psoriasis and psoriatic arthritis? 7
Comparative Outcomes of Kiss Latissimus Dorsi Flap Versus Extended Thoracoabdominal Hatchet Flap for Large Chest Wall Reconstruction: A Retrospective Cohort Study 7
Imaging methyl aminolevulinate-fluorescence of basal cell carcinoma with a new photographic system 6
Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus 6
The psoriatic patient profile for infliximab 6
Assessing the beneficial impact of a patient support program in secukinumab-treated patients with psoriasis in italy 6
Terapia fotodinamica e solaraze in associazione nel trattamento delle precancerosi e tumori cutanei non melanoma: risultati preliminari 6
Adherence with golimumab treatment in patients with psoriatic arthritis: impact on health-related quality of life and other patient-reported outcomes 6
Burden of Disease in Real-Life Setting of Patients With Atopic Dermatitis: Italian Data From the MEASURE-AD Study 6
Psoriasis rupioides, an uncommon form of a very common disease: A case report 5
Chronic spontaneous urticaria treated with omalizumab: report of two cases 5
A consensus-based approach on the management of patients with both psoriasis and psoriatic arthritis in the dermatological and rheumatological settings in Italy: The ADOI PSO-Amore Project 5
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis 5
Long-term efficacy and safety of apremilast in psoriatic arthritis: Focus on skin manifestations and special populations 5
Consensus on the place in therapy of TNF-α inhibitors in the treatment of patients with chronic plaque psoriasis 4
Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experience 4
Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study 4
Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis 4
Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study 4
Sequential treatment of psoriasis with infliximab followed by cyclosporin: Preliminary results of an open-label prospective study 4
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study 4
DERMATOFITOSI: CONTRIBUTO CLINICO-EPIDEMIOLOGICO 4
A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis 4
Consensus on the management of patients with psoriatic arthritis in a dermatology setting 4
ADALIMUMAB BEYOND APPROVED INDICATIONS: CASE OF THERAPEUTIC SUCCESS AND FUTURE PERSPECTIVES 4
An Italian multicentre study on adult atopic dermatitis: persistent versus adult-onset disease 4
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study – IL PSO (ITALIAN LANDSCAPE PSORIASIS) 4
Verrucous Nodule of the Finger 4
DERMATITE SEBORROICA: NOSTRA ESPERIENZA CON TERBINAFINA PER VIA ORALE E TOPICA 4
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 4
Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: DIMESKIN-2, a Multicentre Single-Arm Phase IIIb Study 4
A rare skin infection in atopic dermatitis: A case report 4
Management of psoriasis and possible complications in patients treated long term with Efalizumab 4
Effectiveness End Points in Real-World Studies on Biological Therapies in Psoriasis: Systematic Review with Focus on Drug Survival 3
Efalizumab efficacy in the treatment of moderate-severe psoriasis in patients with high cardiovascular risk 3
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis 3
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study 3
Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study 3
Diagnosis and management of moderate to severe atopic dermatitis in adolescents. A Consensus by the Italian Society of Dermatology and Venereology (SIDemaSt), the Italian association of Hospital Dermatologists and Public Health (aDoI), the Italian association of Hospital and territorial allergists and Immunologists (aaIIto), the Italian Society of allergy, asthma and Clinical Immunology (SIaaIC), the Italian Society of Pediatric allergy and Immunology (SIaIP), the Italian Society of allergological, occupational and environmental Dermatology (SIDaPa), and the Italian Society of Pediatric Dermatology (SIDerP) 3
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study 3
Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice 3
Photodynamic therapy of acne using methyl aminolaevulinate diluted to 4% together with low doses of red light [7] 3
Italian guidelines for therapy of atopic dermatitis—Adapted from consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) 3
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience 3
BLAISE: considerazioni su di un caso 3
Manifestazioni cutanee in 3 pazienti con COVID-19 3
Re-induction as a possible alternative modality of dose escalation of infliximab: A prospective evaluation in a small series of psoriatic patients 3
HLA-Cw6 allele and efficacy of secukinumab 3
Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study 3
La ciclosporina A nel lichen 3
Dermatite seborroica e terbinafina: efficacia e tollerabilit{\`a} 3
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis 3
Adalimumab treatment in long-term sufferers of pherocitosis, psoriasis and arthropatic psoriasis 3
Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis 3
Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis 3
A Novel Smart Treatment For Actinic Keratosis 3
Gender differences in adult atopic dermatitis and clinical implication: Results from a nationwide multicentre study 3
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study 3
Una parassitosi insolita alle nostre latitudini 3
Dupilumab Treatment in Children Aged 6–11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study 3
Thalidomide and discoid lupus erythematosus: case series and review of literature 3
HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa 3
TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis 3
Treatment of psoriasis vulgaris with calcipotriol betamethasone dipropionate combination followed by calcipotriol and assessment of the adjuvant basic use of urea-based emollients 3
Italian expert consensus for the management of actinic keratosis in immunocompetent patients 3
An off­‐label adalimumab treatment for hidradenitis suppurativa: a case report 3
Update on the Management of Pediatric Psoriasis: An Italian Consensus 3
A “local” sporotrichosis: a case report 3
Secukinumab improves patient perception of anxiety and depression in patients with moderate to severe psoriasis: A post hoc analysis of the supreme study 3
Rapid improvement of nail psoriasis after short term use of ustekinumab administration 3
C-reactive protein and markers for thrombophilia in patients with chronic plaque psoriasis 3
Nail psoriasis: new therapeutic strategy 3
National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis 3
Tildrakizumab for treatment of moderate to severe psoriasis: an expert opinion of efficacy, safety, and use in special populations 3
Psoriasis: The Relationship Between Vitamin D3, LL-­‐37, Calcium and Phosphorus Levels 2
Pustular psoriasis and Efalizumab: a case report 2
Risankizumab: Daily Practice Experience of High Need Patients 2
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study 2
A rare case of non-ketotic hyperglycaemic hemichorea (NHH) in a patient suffering from psoriasis 2
Trattamento con Efalizumab in paziente con psoriasi cronica a placche resistente ad altre terapie 2
Real-world effectiveness and safety of guselkumab for the treatment of psoriasis: A 6-month prospective study in a series of psoriatic patients 2
JCV virus and biologics: some consideration 2
La piattaforma online della dermatite atopica dell'adulto: lavori in corso 2
Psoriasi Severa diffusa e mantoux positiva: quale biologico 2
Effectiveness of apremilast in real life in patients with psoriasis: A longitudinal study 2
Lymphocutaneous sporotrichosis in an immunocompetent patient: A case report from extreme southern Italy 2
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations 1
Totale 391
Categoria #
all - tutte 1.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.864


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2026/2027391 0 254 137 0 0 0 0 0 0 0 0 0
Totale 391